A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain
Clinical trial NCT01820715 · COMPLETED
Trial details
- NCT number
- NCT01820715
- Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2013-04-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.